We are taking these data in consideration and increasing our glioblastoma patients’ samples and primary cultures in order to probe a cause–effect relationship between CLytA-DAAO activity and NFE2L2 expression in glioblastoma. The gene discussed is NFE2L2; the disease is glioblastoma.